Funding for this research was provided by:
European Commission (643706)
Text and Data Mining valid from 2018-09-14
Received: 9 October 2017
Accepted: 25 June 2018
First Online: 14 September 2018
Ethics approval and consent to participate
: Information is provided for the three countries as follows:<i>England</i>. The National Health Service (NHS) ethical approval is at three levels and is administered through the Integrated Research Application System (IRAS, project ID 218538). In addition to the favourable opinion from the South East Coast - Surrey Research Ethics Committee of NHS Health Research Authority (REC reference 17/LO/0574), site approvals were also obtained from the two health trusts which cover the two hospitals where the pilot trial is conducted: the Royal Surrey County Hospital of the Royal Surrey NHS Trust (Guildford) and the Ashford and St. Peter’s Hospital of Ashford St Peter’s NHS Trust (Chertsey).<i>Greece</i><b>.</b> – Favourable opinions were obtained from the Department of Neurology, Faculty of Medicine, University of Ioannina. The approval reference number is No. 3 / 22–2-2017 (topic 19).<i>Italy</i>. – Approval was obtained from the San Camillo/IRCCS Hospital Foundation, Via Alberoni, 70, 30,126 Lido VE, Italy and Foundation Saint Lucia, Via Ardeatina, 306/354, 00142 Rome RM, Italy. The ethics approval reference numbers are 66A/CESC and CE/PROG.554 respectively.All changes or modifications to the protocol will be brought to the attention of these authorities for necessary approval.Informed consent will be obtained from all participants in the study.
: Consent has been obtained from a patient and a clinician in one of the pictures provided as Fig. InternalRef removed .
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.